CONTEXT: Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. The selection of first-line therapies for ovulation induction is empiric. OBJECTIVE: The aim of the study was to develop a clinically useful predictive model of live birth with varying ovulation induction methods. DESIGN, SETTING, AND PARTICIPANTS: We built four prognostic models from a large multicenter randomized controlled infertility trial of 626 women with PCOS performed at academic health centers in the United States to predict success of ovulation, conception, pregnancy, and live birth, evaluating the influence of patients' baseline characteristics. INTERVENTIONS:Ovulation was induced with clomiphene, metformin, or the combination of both for up to six cycles or conception. MAIN OUTCOME MEASURE: The primary outcome of the trial was the rate of live births. RESULTS:Baseline free androgen index, baseline proinsulin level, interaction of treatment arm with body mass index, and duration of attempting conception were significant predictors in all four models. History of a prior loss predicted ovulation and conception, but not pregnancy or live birth. A modified Ferriman Gallwey hirsutism score of less than 8 was predictive of conception, pregnancy, and live birth (although it did not predict ovulation success). Age was a divergent predictor based on outcome; age greater than 34 predicted ovulation, whereas age less than 35 was a predictive factor for a successful pregnancy and live birth. Smoking history had no predictive value. CONCLUSIONS: A live birth prediction chart developed from basic clinical parameters (body mass index, age, hirsutism score, and duration of attempting conception) may help physicians counsel and select infertility treatments for women with PCOS.
RCT Entities:
CONTEXT: Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. The selection of first-line therapies for ovulation induction is empiric. OBJECTIVE: The aim of the study was to develop a clinically useful predictive model of live birth with varying ovulation induction methods. DESIGN, SETTING, AND PARTICIPANTS: We built four prognostic models from a large multicenter randomized controlled infertility trial of 626 women with PCOS performed at academic health centers in the United States to predict success of ovulation, conception, pregnancy, and live birth, evaluating the influence of patients' baseline characteristics. INTERVENTIONS: Ovulation was induced with clomiphene, metformin, or the combination of both for up to six cycles or conception. MAIN OUTCOME MEASURE: The primary outcome of the trial was the rate of live births. RESULTS: Baseline free androgen index, baseline proinsulin level, interaction of treatment arm with body mass index, and duration of attempting conception were significant predictors in all four models. History of a prior loss predicted ovulation and conception, but not pregnancy or live birth. A modified Ferriman Gallwey hirsutism score of less than 8 was predictive of conception, pregnancy, and live birth (although it did not predict ovulation success). Age was a divergent predictor based on outcome; age greater than 34 predicted ovulation, whereas age less than 35 was a predictive factor for a successful pregnancy and live birth. Smoking history had no predictive value. CONCLUSIONS: A live birth prediction chart developed from basic clinical parameters (body mass index, age, hirsutism score, and duration of attempting conception) may help physicians counsel and select infertility treatments for women with PCOS.
Authors: Anthony J G Hanley; Gail McKeown-Eyssen; Stewart B Harris; Robert A Hegele; Thomas M S Wolever; Jeremy Kwan; Bernard Zinman Journal: Diabetes Care Date: 2002-04 Impact factor: 19.112
Authors: Anthony J G Hanley; Ralph D'Agostino; Lynne E Wagenknecht; Mohammed F Saad; Peter J Savage; Richard Bergman; Steven M Haffner Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: Babak Imani; Marinus J C Eijkemans; Egbert R te Velde; J Dik F Habbema; Bart C J M Fauser Journal: Fertil Steril Date: 2002-01 Impact factor: 7.329
Authors: Andreas Pfützner; Thomas Kunt; Cloth Hohberg; Agnes Mondok; Sabine Pahler; Thomas Konrad; Georg Lübben; Thomas Forst Journal: Diabetes Care Date: 2004-03 Impact factor: 19.112
Authors: Mira Aubuchon; Allen R Kunselman; William D Schlaff; Michael P Diamond; Christos Coutifaris; Sandra A Carson; Michael P Steinkampf; Bruce R Carr; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Evan R Myers; Richard S Legro Journal: J Clin Endocrinol Metab Date: 2011-08-10 Impact factor: 5.958
Authors: Alex J Polotsky; Amanda A Allshouse; Peter R Casson; Christos Coutifaris; Michael P Diamond; Gregory M Christman; William D Schlaff; Ruben Alvero; J C Trussell; Stephen A Krawetz; Nanette Santoro; Esther Eisenberg; Heping Zhang; Richard S Legro Journal: J Clin Endocrinol Metab Date: 2015-04-09 Impact factor: 5.958
Authors: Michael P Diamond; Michael Kruger; Nanette Santoro; Heping Zhang; Peter Casson; William Schlaff; Christos Coutifaris; Robert Brzyski; Gregory Christman; Bruce R Carr; Peter G McGovern; Nicholas A Cataldo; Michael P Steinkampf; Gabriella G Gosman; John E Nestler; Sandra Carson; Evan E Myers; Esther Eisenberg; Richard S Legro Journal: Obstet Gynecol Date: 2012-05 Impact factor: 7.661
Authors: Richard S Legro; William C Dodson; Carol L Gnatuk; Stephanie J Estes; Allen R Kunselman; Juliana W Meadows; James S Kesner; Edward F Krieg; Ann M Rogers; Randy S Haluck; Robert N Cooney Journal: J Clin Endocrinol Metab Date: 2012-10-12 Impact factor: 5.958
Authors: Richard S Legro; Robert G Brzyski; Michael P Diamond; Christos Coutifaris; William D Schlaff; Peter Casson; Gregory M Christman; Hao Huang; Qingshang Yan; Ruben Alvero; Daniel J Haisenleder; Kurt T Barnhart; G Wright Bates; Rebecca Usadi; Scott Lucidi; Valerie Baker; J C Trussell; Stephen A Krawetz; Peter Snyder; Dana Ohl; Nanette Santoro; Esther Eisenberg; Heping Zhang Journal: N Engl J Med Date: 2014-07-10 Impact factor: 91.245